Showing results (131-140 of 319) with videos related to

Sort By:
Pageof 32
Journal of Clinical Gastroenterology|February 22, 2011
Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitisShuji Yamamoto, Hiroshi Nakase, Minoru Matsuura, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 21, 2003
[Clinical usefulness of serum total cholesterol as an index of hypothyroidism in patients after cervical radiation]Yoko Iguma, Chikako Iwai, Masako Okuyama, et al.
Drug Metabolism and Pharmacokinetics|January 6, 2009
Effect of intestinal and hepatic first-pass extraction on the pharmacokinetics of everolimus in ratsAkira Yokomasu, Ikuko Yano, Eriko Sato, et al.
Biochemical Pharmacology|June 22, 2007
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicitySachiko Yokoo, Atsushi Yonezawa, Satohiro Masuda, et al.
Biomed Research International|August 19, 2014
Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile saltsShin-ya Morita, Tomohiro Terada
Journal of Clinical Pharmacology|June 3, 2009
Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantationMasahide Fukudo, Ikuko Yano, Keiko Shinsako, et al.
The Journal of Surgical Research|April 2, 2002
Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimusMasahiro Shimomura, Satohiro Masuda, Hideyuki Saito, et al.
Drug Metabolism and Pharmacokinetics|November 8, 2005
Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1Naoko Kimura, Satohiro Masuda, Yuko Tanihara, et al.
Pageof 32